WRAP announced a strategic investment in Frenel Imaging that secures WRAP exclusive U.S. and NATO commercialization rights to Frenel’s TPiCore® technology. The deal strengthens WRAP’s go-to-market access for the platform, supporting a modest positive outlook for future commercialization.
WRAP announced a strategic investment in Frenel Imaging that secures WRAP exclusive U.S. and NATO commercialization rights to Frenel’s TPiCore® technology. The deal strengthens WRAP’s go-to-market access for the platform, supporting a modest positive outlook for future commercialization.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment